These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18842934)

  • 1. Comparison of Gen-probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden.
    Møller JK; Pedersen LN; Persson K
    J Clin Microbiol; 2008 Dec; 46(12):3892-5. PubMed ID: 18842934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Abbott RealTime CT new formulation assay with two other commercial assays for detection of wild-type and new variant strains of Chlamydia trachomatis.
    Møller JK; Pedersen LN; Persson K
    J Clin Microbiol; 2010 Feb; 48(2):440-3. PubMed ID: 20007394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Boyadzhyan B; Yashina T; Yatabe JH; Patnaik M; Hill CS
    J Clin Microbiol; 2004 Jul; 42(7):3089-93. PubMed ID: 15243065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands.
    van Doornum GJ; Schouls LM; Pijl A; Cairo I; Buimer M; Bruisten S
    J Clin Microbiol; 2001 Mar; 39(3):829-35. PubMed ID: 11230391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Marshall R; Chernesky M; Jang D; Hook EW; Cartwright CP; Howell-Adams B; Ho S; Welk J; Lai-Zhang J; Brashear J; Diedrich B; Otis K; Webb E; Robinson J; Yu H
    J Clin Microbiol; 2007 Mar; 45(3):747-51. PubMed ID: 17202273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.
    Lowe P; O'Loughlin P; Evans K; White M; Bartley PB; Vohra R
    J Clin Microbiol; 2006 Jul; 44(7):2619-21. PubMed ID: 16825397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.
    Schachter J; Chow JM; Howard H; Bolan G; Moncada J
    J Clin Microbiol; 2006 Jul; 44(7):2512-7. PubMed ID: 16825373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the new COBAS TaqMan CT test v2.0 and impact on the proportion of new variant Chlamydia trachomatis by the introduction of diagnostics detecting new variant C trachomatis in Orebro county, Sweden.
    Hadad R; Fredlund H; Unemo M
    Sex Transm Infect; 2009 Jun; 85(3):190-3. PubMed ID: 19060034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chlamydia trachomatis 23S rRNA G1523A variant escaping detection in the Aptima Combo 2 assay (Hologic) was widespread across Denmark in July-September 2019.
    Hadad R; Jensen JS; Westh H; Grønbaek I; Schwartz LJ; Nielsen L; Vang TM; Nielsen R; Weinreich LS; Skov MN; Olsen M; Møller JK; Kolmos B; Unemo M; Hoffmann S
    APMIS; 2020 Jun; 128(6):440-444. PubMed ID: 32202687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine.
    Taylor SN; Liesenfeld O; Lillis RA; Body BA; Nye M; Williams J; Eisenhut C; Hook EW; Van Der Pol B
    Sex Transm Dis; 2012 Jul; 39(7):543-9. PubMed ID: 22706217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay.
    Chernesky M; Jang D; Luinstra K; Chong S; Smieja M; Cai W; Hayhoe B; Portillo E; Macritchie C; Main C; Ewert R
    J Clin Microbiol; 2006 Feb; 44(2):400-5. PubMed ID: 16455891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.
    Chernesky M; Jang D; Portillo E; Chong S; Smieja M; Luinstra K; Petrich A; Macritchie C; Ewert R; Hayhoe B; Sarabia A; Thompson F
    J Clin Microbiol; 2007 Aug; 45(8):2355-8. PubMed ID: 17537943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The verification of nucleic acid amplification testing (Gen-Probe Aptima Assay) for chlamydia trachomatis from ocular samples.
    Kowalski RP; Karenchak LM; Raju LV; Ismail N
    Ophthalmology; 2015 Feb; 122(2):244-7. PubMed ID: 25439605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and nucleic acid sequencing of Chlamydia trachomatis 16S rRNA genes from patient samples lacking the cryptic plasmid.
    An Q; Olive DM
    Mol Cell Probes; 1994 Oct; 8(5):429-35. PubMed ID: 7877640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of strand displacement amplification assay in the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Fontana C; Favaro M; Cicchetti O; Minelli S; Pistoia ES; Favalli C
    Jpn J Infect Dis; 2005 Oct; 58(5):283-8. PubMed ID: 16249622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes.
    Madico G; Quinn TC; Boman J; Gaydos CA
    J Clin Microbiol; 2000 Mar; 38(3):1085-93. PubMed ID: 10699002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.
    Goessens WH; Mouton JW; van der Meijden WI; Deelen S; van Rijsoort-Vos TH; Lemmens-den Toom N; Verbrugh HA; Verkooyen RP
    J Clin Microbiol; 1997 Oct; 35(10):2628-33. PubMed ID: 9316920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples.
    Morré SA; Sillekens P; Jacobs MV; van Aarle P; de Blok S; van Gemen B; Walboomers JM; Meijer CJ; van den Brule AJ
    J Clin Microbiol; 1996 Dec; 34(12):3108-14. PubMed ID: 8940456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence trends in Sweden for the new variant of Chlamydia trachomatis.
    Klint M; Hadad R; Christerson L; Loré B; Anagrius C; Osterlund A; Larsson I; Sylvan S; Fredlund H; Unemo M; Herrmann B
    Clin Microbiol Infect; 2011 May; 17(5):683-9. PubMed ID: 20636428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants.
    Unemo M; Hansen M; Hadad R; Puolakkainen M; Westh H; Rantakokko-Jalava K; Thilesen C; Cole MJ; Boiko I; Lan PT; Golparian D; Ito S; Sundqvist M
    BMC Infect Dis; 2020 Jun; 20(1):419. PubMed ID: 32546213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.